More than half of 'new' drugs are no better than established treatments

A study by the technology-assessment agency IQWiG assessed the 216 drugs that entered the German market in 2011-to-2017. Only a quarter had a 'considerable or major added benefit'.

from Home | Mail Online https://ift.tt/2LH21AK
via Top Stories